Navigation Links
GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
Date:11/26/2007

To 100 To 130

(10-year risk >20%) (100-129: drug optional)

++

2+ Risk factors <130 Greater Than or Equal 10-year risk 10-20%:

(10 year risk Less To 130 Greater Than or Equal

Than or Equal To 20%) To 130

10-year risk <10%:

Greater Than or Equal

To 160

0-1 Risk factor+++ <160 Greater Than or Equal Greater Than or Equal

To 160 To 190

(160-189: LDL-lowering

drug optional)

+ CHD, coronary heart disease

++ Some authorities recommend use of LDL-lowering drugs in this category if an LDL-C level of <100 mg/dL cannot be achieved by therapeutic lifestyle changes. Others prefer use of drugs that primarily modify triglycerides and HDL-C, e.g., nicotinic acid or fibrate. Clinical judgment also may call for deferring drug therapy in this subcategory.

+++ Almost all people with 0-1 risk factor have a 10-year risk <10%; thus, 10-year risk assessment in people with 0-1 risk factor is not necessary.

After the LDL-C goal has been achieved, if the TG is still Greater Than or Equal To 200 mg/dL, non-HDL-C (total-C minus HDL-C) becomes a secondary target of therapy. Non-HDL-C goals are set 30 mg/dL higher than LDL-C goals for each risk category.

At the time of hospitalization for an acute coronary event, consideration can be given to initiating drug therapy at discharge if the LDL-C is Greater Than or Equal To 130 mg/dL (see NCEP Guidelines above).

Since the goa
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
9. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Pearson VUE Signs Exclusive Contract with Educational Resources, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... May 23, 2013 Fresh Healthy Vending ... machines stocked with healthy food and drinks in locations ... company’s in-house, full-service marketing and advertising department has a ... the media for their franchisees, and to promote the ... been featured in many leading publications and TV networks ...
(Date:5/23/2013)... 2013 Jim Fitzpatrick just did it ... developed yet another outside-of-the-box approach to reaching the retail ... brings daily newscasts to the retail automotive industry, blending ... a broadcast news format. , CBTNews.com is an ... Co-anchors Bridget Everett and Russell Brown host the show ...
(Date:5/23/2013)... Springs, FL (PRWEB) May 23, 2013 The ... about redefining retirement. Many Americans are facing a dim life ... the Late Boomers -- those born after 1955 -- carry ... card debt. But all hope for The Golden Years is ... how to reduce debt and keep earning after reaching the ...
(Date:5/23/2013)... "Neisseria meningitidis is an important human pathogen that can ... in humans," Professor Jennings said., "Until now we have ... It has been a long-standing mystery how it attaches ... of the bug and not get any symptoms, while ... why, we need to know the detail of how ...
(Date:5/23/2013)... HealthDay Reporter , , WEDNESDAY, May 22 (HealthDay News) -- ... detecting lung cancer now have more information to help with ... finds that low-dose CT scans pick up significantly more lung ... history of smoking are at high risk for lung cancer, ... doctors have to consider the potential harm of radiation exposure ...
Breaking Medicine News(10 mins):Health News:Fresh Healthy Vending Receives Recent National and Local Media Focus 2Health News:Fitzpatrick Advertising Founder Brings Auto Industry into Focus with CBT News 2Health News:Viewpoints with Terry Bradshaw Presents a Series on Redefining Retirement 2Health News:New discovery in fight against deadly meningococcal disease 2Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 2Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 3
... was getting worse, but she wrote it off as just ... “that time of the month// .” ,“I was ... back pain,” says Ruma, 43. ,After running some ... condition that affects one in 10 women, usually of childbearing ...
... believe that, if they get circumcised, they are protected ... it is not a vaccine// and these men are ... ,“The century-old circumcision ‘experiment’ in the United States ... different?” asks Dan Bollinger, director of ICGI. "We are ...
... for Nepal's Prime Minister Girija Prasad Koirala who, despite his ... temptation" of coming to the SAARC summit. ,Addressing ... the elder statesman of Nepal, also used the occasion to ... ,"I gambled 60 years of my political career to ...
... testosterone, which plays a key role in health and ... ,People suffering with Alzheimer's lack the ability to ... As the disease progresses, individuals may also experience changes ... agitation, as well as delusions or hallucinations. ...
... (LCT) Limited has published evidence outlining the survival and ... in a human patient 10 years after receiving a ... paper published in the March 2007 issue of the ... long-term safety, viability and function of its encapsulated porcine ...
... bra-burning women libbers would love to endorse. // ... Press, revised edition 2001) by authors Sydney Ross Singer and Soma ... that wearing a bra throughout the day increased woman’s risk of ... have discovered a possible trigger for breast cancer in interviews of ...
Cached Medicine News:Health News:Hope for Ending the Pain, Infertility of Endometriosis? 2Health News:Hope for Ending the Pain, Infertility of Endometriosis? 3Health News:Promoting Circumcision to Prevent HIV is Misguided and Will Backfire: ICGI 2Health News:Transplanted Pig Cells in Human Produce Insulin 2Health News:Transplanted Pig Cells in Human Produce Insulin 3Health News:Breast Cancer and Bra Wearing: Possibly Linked 2
(Date:5/23/2013)... , May 23, 2013  Omeros Corporation (NASDAQ: ... Investigational New Drug Application (IND) to evaluate OMS824 ... U.S. Food and Drug Administration (FDA). OMS824 selectively ... areas of the brain linked to a wide ... disease and schizophrenia. OMS824 has shown promising results ...
(Date:5/23/2013)... 23, 2013 SynCardia Systems, Inc. ( www.syncardia.com ... Health Canada and CE ( Europe ) ... Science Centre in Scotland , which ... SynCardia temporary Total Artificial Heart powered by ... million Bodyworks Exhibition, one of the most advanced exhibitions ...
(Date:5/23/2013)... , May 23, 2013  PAREXEL International Corporation ... will be presenting at the Jefferies Healthcare Conference in ... Vice President and Chief Financial Officer, will be making ... 1:30 p.m. ET on Monday, June 3, 2013. ... through the "Investors" section of PAREXEL,s website at ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 2Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 3PAREXEL International To Present At Jefferies Healthcare Conference 2
... Endo (Nasdaq: ENDP ) announced today that American Medical ... of the Endo devices operating company in July 2012. While the ... been initiated. Mr. Bihl joined Endo as Group President ... President and Chief Executive Officer of AMS in April 2008. ...
... EMERYVILLE, Calif., March 28, 2012 Bionovo, Inc. (OTCQB: BNVI), ... of safe and effective treatments for women,s health and ... Monitoring Board (DSMB) recommended that the Phase 3 trial ... initial review of its clinical safety and tolerability data. ...
Cached Medicine Technology:Endo Announces Departure of American Medical Systems President 2Bionovo's Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™ 2Bionovo's Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™ 3Bionovo's Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™ 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: